The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1
Ovarian cancer (OC) is one of the most common malignancies of the female reproductive system. The miRNA miR-582-3p is associated with a variety of tumors, and the aim of this study was to investigate the role and mechanisms of miR-582-3p specifically in ovarian carcinogenesis and progression. Low ex...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ef39530e11c4874ad16bd1bb1bfb80e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0ef39530e11c4874ad16bd1bb1bfb80e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0ef39530e11c4874ad16bd1bb1bfb80e2021-11-26T11:19:49ZThe MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG12165-59792165-598710.1080/21655979.2021.2003662https://doaj.org/article/0ef39530e11c4874ad16bd1bb1bfb80e2021-11-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.2003662https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987Ovarian cancer (OC) is one of the most common malignancies of the female reproductive system. The miRNA miR-582-3p is associated with a variety of tumors, and the aim of this study was to investigate the role and mechanisms of miR-582-3p specifically in ovarian carcinogenesis and progression. Low expression of miR-582-3p was noted in OC tissue and cell lines, and lower expression of miR-582-3p correlated with lower overall survival in OC patients. Knockdown of miR-582-3p promoted the proliferation and migration of OC cells, while overexpression inhibited them. TUG1, a long non-coding RNA, was found to bind to miR-582-3p, and inhibition of lncRNA TUG1 decreased viability and migration and weakened the effect of miR-582-3p knockdown in OC cells. Implantation of OC cells with reduced miR-582-3p caused increased tumor growth, while lncRNA TUG1 knockdown suppressed tumor growth and relieved the impact of reduced miR-582-3p in vivo. Phosphorylation of AKT and mTOR were significantly enhanced with decreased miR-582-3p expression, but lncRNA TUG1 knockdown attenuated this trend in vitro and in vivo. The novel miR-582-3p represses the malignant properties of OC via the AKT/mTOR signaling pathway by targeting lncRNA TUG1. This axis may represent valuable prognostic biomarkers and therapeutic targets for OC.Tianyu DaiJunhui LiangWei LiuYonghui ZouFeifei NiuMengqing LiHaomeng ZhangChangzhong LiMingjun FanGuoying CuiTaylor & Francis Grouparticlemir-582-3povarian cancerlncrna tug1akt/mtor signaling pathwayBiotechnologyTP248.13-248.65ENBioengineered, Vol 0, Iss 0 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
mir-582-3p ovarian cancer lncrna tug1 akt/mtor signaling pathway Biotechnology TP248.13-248.65 |
spellingShingle |
mir-582-3p ovarian cancer lncrna tug1 akt/mtor signaling pathway Biotechnology TP248.13-248.65 Tianyu Dai Junhui Liang Wei Liu Yonghui Zou Feifei Niu Mengqing Li Haomeng Zhang Changzhong Li Mingjun Fan Guoying Cui The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1 |
description |
Ovarian cancer (OC) is one of the most common malignancies of the female reproductive system. The miRNA miR-582-3p is associated with a variety of tumors, and the aim of this study was to investigate the role and mechanisms of miR-582-3p specifically in ovarian carcinogenesis and progression. Low expression of miR-582-3p was noted in OC tissue and cell lines, and lower expression of miR-582-3p correlated with lower overall survival in OC patients. Knockdown of miR-582-3p promoted the proliferation and migration of OC cells, while overexpression inhibited them. TUG1, a long non-coding RNA, was found to bind to miR-582-3p, and inhibition of lncRNA TUG1 decreased viability and migration and weakened the effect of miR-582-3p knockdown in OC cells. Implantation of OC cells with reduced miR-582-3p caused increased tumor growth, while lncRNA TUG1 knockdown suppressed tumor growth and relieved the impact of reduced miR-582-3p in vivo. Phosphorylation of AKT and mTOR were significantly enhanced with decreased miR-582-3p expression, but lncRNA TUG1 knockdown attenuated this trend in vitro and in vivo. The novel miR-582-3p represses the malignant properties of OC via the AKT/mTOR signaling pathway by targeting lncRNA TUG1. This axis may represent valuable prognostic biomarkers and therapeutic targets for OC. |
format |
article |
author |
Tianyu Dai Junhui Liang Wei Liu Yonghui Zou Feifei Niu Mengqing Li Haomeng Zhang Changzhong Li Mingjun Fan Guoying Cui |
author_facet |
Tianyu Dai Junhui Liang Wei Liu Yonghui Zou Feifei Niu Mengqing Li Haomeng Zhang Changzhong Li Mingjun Fan Guoying Cui |
author_sort |
Tianyu Dai |
title |
The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1 |
title_short |
The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1 |
title_full |
The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1 |
title_fullStr |
The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1 |
title_full_unstemmed |
The MIRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1 |
title_sort |
mirna mir-582-3p suppresses ovarian cancer progression by targeting akt/mtor signaling via lncrna tug1 |
publisher |
Taylor & Francis Group |
publishDate |
2021 |
url |
https://doaj.org/article/0ef39530e11c4874ad16bd1bb1bfb80e |
work_keys_str_mv |
AT tianyudai themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT junhuiliang themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT weiliu themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT yonghuizou themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT feifeiniu themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT mengqingli themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT haomengzhang themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT changzhongli themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT mingjunfan themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT guoyingcui themirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT tianyudai mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT junhuiliang mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT weiliu mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT yonghuizou mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT feifeiniu mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT mengqingli mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT haomengzhang mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT changzhongli mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT mingjunfan mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 AT guoyingcui mirnamir5823psuppressesovariancancerprogressionbytargetingaktmtorsignalingvialncrnatug1 |
_version_ |
1718409451819499520 |